These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31877321)

  • 1. Anti-neuroinflammatory, protective effects of the synthetic microneurotrophin BNN-20 in the advanced dopaminergic neurodegeneration of "weaver" mice.
    Panagiotakopoulou V; Botsakis K; Delis F; Mourtzi T; Tzatzarakis MN; Dimopoulou A; Poulia N; Antoniou K; Stathopoulos GT; Matsokis N; Charalampopoulos I; Gravanis A; Angelatou F
    Neuropharmacology; 2020 Mar; 165():107919. PubMed ID: 31877321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BNN-20, a synthetic microneurotrophin, strongly protects dopaminergic neurons in the "weaver" mouse, a genetic model of dopamine-denervation, acting through the TrkB neurotrophin receptor.
    Botsakis K; Mourtzi T; Panagiotakopoulou V; Vreka M; Stathopoulos GT; Pediaditakis I; Charalampopoulos I; Gravanis A; Delis F; Antoniou K; Zisimopoulos D; Georgiou CD; Panagopoulos NT; Matsokis N; Angelatou F
    Neuropharmacology; 2017 Jul; 121():140-157. PubMed ID: 28461162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of substantia nigra neurogenesis in homeostasis and dopaminergic degeneration: beneficial effects of the microneurotrophin BNN-20.
    Mourtzi T; Dimitrakopoulos D; Kakogiannis D; Salodimitris C; Botsakis K; Meri DK; Anesti M; Dimopoulou A; Charalampopoulos I; Gravanis A; Matsokis N; Angelatou F; Kazanis I
    Stem Cell Res Ther; 2021 Jun; 12(1):335. PubMed ID: 34112234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF21 Protects Dopaminergic Neurons in Parkinson's Disease Models Via Repression of Neuroinflammation.
    Fang X; Ma J; Mu D; Li B; Lian B; Sun C
    Neurotox Res; 2020 Mar; 37(3):616-627. PubMed ID: 31997152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson's disease.
    Elgueta D; Aymerich MS; Contreras F; Montoya A; Celorrio M; Rojo-Bustamante E; Riquelme E; González H; Vásquez M; Franco R; Pacheco R
    Neuropharmacology; 2017 Feb; 113(Pt A):110-123. PubMed ID: 27693549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 17β-Estradiol/N-acetylcysteine interaction enhances the neuroprotective effect on dopaminergic neurons in the weaver model of dopamine deficiency.
    Botsakis K; Theodoritsi S; Grintzalis K; Angelatou F; Antonopoulos I; Georgiou CD; Margarity M; Matsokis NA; Panagopoulos NT
    Neuroscience; 2016 Apr; 320():221-9. PubMed ID: 26852701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Sonic hedgehog signal by Purmorphamine, in a mouse model of Parkinson's disease, protects dopaminergic neurons and attenuates inflammatory response by mediating PI3K/AKt signaling pathway.
    Shao S; Wang GL; Raymond C; Deng XH; Zhu XL; Wang D; Hong LP
    Mol Med Rep; 2017 Aug; 16(2):1269-1277. PubMed ID: 28627590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-Ala2-GIP-glu-PAL is neuroprotective in a chronic Parkinson's disease mouse model and increases BNDF expression while reducing neuroinflammation and lipid peroxidation.
    Li Y; Liu W; Li L; Hölscher C
    Eur J Pharmacol; 2017 Feb; 797():162-172. PubMed ID: 27913104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease.
    Pisanu A; Lecca D; Mulas G; Wardas J; Simbula G; Spiga S; Carta AR
    Neurobiol Dis; 2014 Nov; 71():280-91. PubMed ID: 25134730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neuroprotective action of lenalidomide on rotenone model of Parkinson's Disease: Neurotrophic and supportive actions in the substantia nigra pars compacta.
    Cankara FN; Günaydın C; Bilge SS; Özmen Ö; Kortholt A
    Neurosci Lett; 2020 Nov; 738():135308. PubMed ID: 32932183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effect of curcumin-I in copper-induced dopaminergic neurotoxicity in rats: A possible link with Parkinson's disease.
    Abbaoui A; Chatoui H; El Hiba O; Gamrani H
    Neurosci Lett; 2017 Nov; 660():103-108. PubMed ID: 28919537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2,3,5,4'-Tetrahydroxystilbene-2-O-β-d-glucoside attenuates MPP+/MPTP-induced neurotoxicity in vitro and in vivo by restoring the BDNF-TrkB and FGF2-Akt signaling axis and inhibition of apoptosis.
    Yu Y; Lang XY; Li XX; Gu RZ; Liu QS; Lan R; Qin XY
    Food Funct; 2019 Sep; 10(9):6009-6019. PubMed ID: 31482900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effects of paeonol on methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid-induced Parkinson's disease in mice.
    Shi X; Chen YH; Liu H; Qu HD
    Mol Med Rep; 2016 Sep; 14(3):2397-404. PubMed ID: 27484986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aucubin alleviates glial cell activation and preserves dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian mice.
    Zhu YL; Sun MF; Jia XB; Zhang PH; Xu YD; Zhou ZL; Xu ZH; Cui C; Chen X; Yang XS; Shen YQ
    Neuroreport; 2018 Sep; 29(13):1075-1083. PubMed ID: 29985188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Montelukast treatment protects nigral dopaminergic neurons against microglial activation in the 6-hydroxydopamine mouse model of Parkinson's disease.
    Jang H; Kim S; Lee JM; Oh YS; Park SM; Kim SR
    Neuroreport; 2017 Mar; 28(5):242-249. PubMed ID: 28178069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colchicine protects dopaminergic neurons in a rat model of Parkinson's disease.
    Salama M; Ellaithy A; Helmy B; El-Gamal M; Tantawy D; Mohamed M; Sheashaa H; Sobh M; Arias-Carrión O
    CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):836-43. PubMed ID: 23198691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Rho-kinase by Fasudil protects dopamine neurons and attenuates inflammatory response in an intranasal lipopolysaccharide-mediated Parkinson's model.
    He Q; Li YH; Guo SS; Wang Y; Lin W; Zhang Q; Wang J; Ma CG; Xiao BG
    Eur J Neurosci; 2016 Jan; 43(1):41-52. PubMed ID: 26565388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activin A protects midbrain neurons in the 6-hydroxydopamine mouse model of Parkinson's disease.
    Stayte S; Rentsch P; Li KM; Vissel B
    PLoS One; 2015; 10(4):e0124325. PubMed ID: 25902062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taurine protects dopaminergic neurons in a mouse Parkinson's disease model through inhibition of microglial M1 polarization.
    Che Y; Hou L; Sun F; Zhang C; Liu X; Piao F; Zhang D; Li H; Wang Q
    Cell Death Dis; 2018 Apr; 9(4):435. PubMed ID: 29568078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.